Trestle Biotherapeutics

👥 6 employees💰 Last funded Mar 2021
Biotechnology🌐 trestlebio.com
Website LinkedIn
Trestle Biotherapeutics, Inc. is a preclinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Trestle Biotherapeutics?
Trestle Biotherapeutics has 1 investors on record on gritt.io.
When did Trestle Biotherapeutics last raise funding?
The most recent investment in Trestle Biotherapeutics recorded on gritt.io was in March 2021.
What industry is Trestle Biotherapeutics in?
Trestle Biotherapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.